Lurtotecan Uses, Dosage, Side Effects and more
Lurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Lurtotecan |
| Generic | Lurtotecan |
| Lurtotecan Other Names | Lurtotecan |
| Type | |
| Formula | C28H30N4O6 |
| Weight | Average: 518.57 Monoisotopic: 518.216534702 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
